AI that starts with the outcome
Healthcare AI should not begin with a vendor demo. It should begin with the decision, workflow, patient risk, operational pressure or cost problem that needs to change.
Healthcare AI consulting
Practical, board-ready and implementation-minded support for healthcare organizations that want AI to improve outcomes, reduce friction, protect trust and create measurable value.
Healthcare AI should not begin with a vendor demo. It should begin with the decision, workflow, patient risk, operational pressure or cost problem that needs to change.
Move with pace, but with clear ownership, defined decision rights, model oversight, clinical validation, data controls and escalation paths.
Strategy only matters when it changes practice. Engagements are designed around adoption, operating reality, measurable benefits and sustained capability.
Why this matters
The hard part is rarely the algorithm alone. The hard part is aligning clinical need, data quality, information governance, incentives, operating workflows, procurement, compliance, executive sponsorship and frontline adoption.
Richard Jones brings senior strategic thinking, practical transformation experience and AI fluency to help healthcare leaders define where AI can create value, where it can create risk, and what needs to be true before scaling.
How Richard helps
This work is for boards, CEOs, founders, investors, health system leaders, payers, healthcare technology companies and transformation teams that need a clear AI position and a credible path to results.
Identify the areas where AI can drive defensible value, avoid distraction and connect investment to measurable operational or clinical outcomes.
Define the practical controls required for responsible AI, including ownership, approval routes, model monitoring, privacy, transparency and executive accountability.
Support leaders who need high-calibre AI and strategy direction without adding a permanent senior executive before the organization is ready.
Challenge claims, pressure-test business cases, assess market positioning and help teams decide what to buy, build, partner on or stop.
Relevant healthcare AI priorities
Use data and AI to understand demand, capacity, scheduling friction and missed appointments.
Frame predictive, operational and workflow interventions that address bottlenecks, avoidable returns and value-based care exposure.
Assess whether AI-enabled support is usable, safe, clinically relevant and designed to reduce noise rather than add it.
Prioritize use cases that reduce burden, improve documentation quality and make work easier for clinical and operational teams.
Help healthcare technology companies sharpen their value proposition, route to market, evidence story and buyer relevance.
Test AI claims, risk, defensibility, adoption potential, scalability and whether the business model is strong enough to survive scrutiny.
Colleague perspective
For healthcare data strategy, governance and operational AI readiness, Richard values the perspective of colleague Chris Hutchins of Hutchins Data Strategy Consultants.
Chris brings long experience in healthcare data, analytics and AI leadership, with a focus on practical governance, clinical alignment, responsible implementation and making data work in real healthcare environments. Where a client challenge benefits from that specialist depth, Richard can draw on trusted colleague insight to strengthen the work.
Ways to work together
FAQs
Healthcare AI has to work inside clinical, operational, regulatory and trust constraints. The work must account for patient safety, protected health information, clinician adoption, governance, reimbursement pressure, interoperability and the consequences of getting decisions wrong.
Start with both, but keep each proportionate. A real use case gives governance something concrete to govern. A clear governance frame prevents the use case from becoming an unmanaged risk. The goal is responsible pace, not bureaucracy.
AI readiness depends on data quality, lineage, ownership, access controls, interoperability, workflow context and whether teams trust the data enough to act on it. If those foundations are weak, the model may be accurate in theory and unusable in practice.
Prioritize use cases where the problem is important, the outcome can be measured, the data is available, the workflow can absorb the change, risk can be governed and there is clear executive sponsorship. Avoid choosing projects simply because the technology looks impressive.
Yes, but only when it is designed around real clinical workflows. Poorly integrated AI can add alerts, documentation burden and distrust. Useful AI removes friction, supports judgement, respects context and is monitored after deployment.
The priority risks are patient safety, privacy, bias, data leakage, vendor overclaiming, model drift, unclear accountability, regulatory exposure and loss of clinician or patient trust. These need explicit ownership before AI is scaled.
Scaling requires more than a successful pilot. It needs defined owners, adoption planning, training, performance metrics, monitoring cadence, change management, governance, budget clarity and an implementation roadmap that survives outside the innovation team.
Bring the challenge, the ambition or the difficult board question. Richard will help turn it into a clear strategic position and a practical path forward.